AI-Focused Biotech Seeks Chapter 11 To Rework $9M Debt
Life science company HTG Molecular Diagnostics Inc. has sought Chapter 11 protection in Delaware, citing a string of failed drug development partnerships followed by the COVID-19 pandemic putting a damper on...To view the full article, register now.
Already a subscriber? Click here to view full article